These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11477311)

  • 1. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion.
    Shaw LM; Holt DW; Oellerich M; Meiser B; van Gelder T
    Ther Drug Monit; 2001 Aug; 23(4):305-15. PubMed ID: 11477311
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring of mycophenolic acid in clinical transplantation.
    Shaw LM; Pawinski T; Korecka M; Nawrocki A
    Ther Drug Monit; 2002 Feb; 24(1):68-73. PubMed ID: 11805725
    [No Abstract]   [Full Text] [Related]  

  • 3. Scientific principles for mycophenolic acid therapeutic drug monitoring.
    Shaw LM; Korecka M; Aradhye S; Grossman R; Barker C; Naji A; Brayman KL
    Transplant Proc; 1998 Aug; 30(5):2234-6. PubMed ID: 9723454
    [No Abstract]   [Full Text] [Related]  

  • 4. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
    Nicholls AJ
    Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic monitoring of mycophenolic acid. A consensus panel report.
    Shaw LM; Nicholls A; Hale M; Armstrong VW; Oellerich M; Yatscoff R; Morris RE; Holt DW; Venkataramanan R; Haley J; Halloran P; Ettenger R; Keown P; Morris RG
    Clin Biochem; 1998 Jul; 31(5):317-22. PubMed ID: 9721428
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic drug monitoring for mycophenolic acid is value for (little) money.
    van Gelder T
    Clin Pharmacol Ther; 2011 Aug; 90(2):203-4. PubMed ID: 21772294
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.
    Shaw LM; Korecka M; van Breeman R; Nowak I; Brayman KL
    Clin Biochem; 1998 Jul; 31(5):323-8. PubMed ID: 9721429
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic monitoring of mycophenolate mofetil.
    Jeong H; Kaplan B
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):184-91. PubMed ID: 17699403
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?
    Stephan A; Masri MA; Barbari A; Kamel G; Karam A; Kilani H
    Transplant Proc; 2001 Aug; 33(5):2778-9. PubMed ID: 11498157
    [No Abstract]   [Full Text] [Related]  

  • 11. Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
    Grasser B; Iberer F; Schaffellner S; Kniepeiss D; Stauber R; Koshsorur G; Rehak P; Tscheliessnigg KH
    Transplant Proc; 2001 May; 33(3):2154-6. PubMed ID: 11377484
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil: how to further improve using an already successful drug?
    van Gelder T
    Am J Transplant; 2005 Feb; 5(2):199-200. PubMed ID: 15643976
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamic monitoring of immunosuppressive drugs.
    Yatscoff RW; Langman LJ; LeGatt DF
    Transplant Proc; 1996 Dec; 28(6):3013-5. PubMed ID: 8962169
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.
    Hesse CJ; Vantrimpont P; van Riemsdijk-van Overbeeke IC; van Gelder T; Balk AH; Weimar W
    Transplant Proc; 2001 May; 33(3):2163-4. PubMed ID: 11377487
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.
    Le Meur Y; Borrows R; Pescovitz MD; Budde K; Grinyo J; Bloom R; Gaston R; Walker RG; Kuypers D; van Gelder T; Kiberd B
    Transplant Rev (Orlando); 2011 Apr; 25(2):58-64. PubMed ID: 21454067
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic drug monitoring of mycophenolates: why make simple things complicated?
    Kuypers DR; van Gelder T
    Transplant Rev (Orlando); 2011 Apr; 25(2):45-6. PubMed ID: 21477747
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil.
    Lipsky JJ
    Lancet; 1996 Nov; 348(9038):1357-9. PubMed ID: 8918281
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil.
    Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
    Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
    Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W
    Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?
    Mourad M; Wallemacq P; König J; de Frahan EH; Eddour DC; De Meyer M; Malaise J; Squifflet JP
    Clin Pharmacokinet; 2002; 41(5):319-27. PubMed ID: 12036390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.